Dr. Ramcharitha Kandikatla, MD

Dr. Kandikatla practices at Medical Center Hospital in Odessa, Texas, part of Medical Center Health System.

Dr. Kandikatla's NPI, 1821409673, was assigned on May 14, 2014. Dr. Kandikatla holds Texas license R6027.

Dr. Kandikatla's primary practice is Medical Center Hospital, at 500 W 4th Street, Odessa, TX 79761 in Ector County. The practice phone is (432) 640-4000.

Dr. Kandikatla's primary practice is Medical Center Hospital in Odessa, Texas, part of Medical Center Health System. The medical group on file is Medical Center Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kandikatla practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Kandikatla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kandikatla is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kandikatla is licensed in Texas.

Dmand AI lists atherosclerosis, cardiac arrhythmia, congestive heart failure, gastrointestinal inflammation, gastrointestinal obstruction, heart attack, kidney failure and lung disease: COPD, asthma or bronchitis among the conditions Dr. Kandikatla treats.

CMS data shows 855 Medicare services from Dr. Kandikatla across 6 procedure codes in 2024, for 349 Medicare patients. Medicare paid $58,253 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 349 Medicare patients who saw Dr. Kandikatla in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kandikatla's median patient age at 64, with 50% women.

In 2024, Dr. Kandikatla wrote 330 Medicare Part D claims for 130 patients. 86% of them were for generic drugs. CMS names the drug for 182 of them, across 9 drugs with 11 or more claims each, at $15,074 in total drug cost. In 2023, CMS named 152 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kandikatla for performance year 2024, reported as part of a group. Dr. Kandikatla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Kandikatla in 2017. Dr. Kandikatla's most frequent co-authors are Kalyan Chakrala, DO and Hira I. Cheema, MD.

CMS Open Payments shows 11 general payments to Dr. Kandikatla from 7 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $140.

Dr. Kandikatla is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.